7JY-29659-50260
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 468 / IN
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body achesAdult check-in
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-16
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-19
- 2021-07-17
-
2022-01-16
Survey response — 12 months, dose 2MedDRA: COVID-19, Pregnancy, Tachycardia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Had Covid-19 at the end of October Currently have tachycardia in pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-16 | Unsuccessful |
Free text
Release 10 — 12 months, dose 2
Symptoms: Had Covid-19 at the end of October Currently have tachycardia in pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release